Carbon source regulates polysaccharide capsule biosynthesis in


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
15 11 2019
Historique:
received: 23 08 2019
revised: 02 10 2019
pubmed: 9 10 2019
medline: 17 6 2020
entrez: 10 10 2019
Statut: ppublish

Résumé

The exopolysaccharide capsule of

Identifiants

pubmed: 31594867
pii: S0021-9258(20)30721-3
doi: 10.1074/jbc.RA119.010764
pmc: PMC6873171
doi:

Substances chimiques

Polysaccharides, Bacterial 0
Fructose 30237-26-4
Sucrose 57-50-1
Carbon 7440-44-0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17224-17238

Informations de copyright

© 2019 Troxler et al.

Références

J Biol Chem. 2013 Sep 6;288(36):25976-85
pubmed: 23897812
Infect Immun. 2016 Mar 24;84(4):1016-1031
pubmed: 26787724
PLoS Pathog. 2016 Jul 07;12(7):e1005633
pubmed: 27389401
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Nucleic Acids Res. 2018 Nov 2;46(19):9990-10006
pubmed: 30165663
Clin Microbiol Rev. 2015 Jul;28(3):871-99
pubmed: 26085553
Biochim Biophys Acta. 1960 Apr 22;39:508-18
pubmed: 14413322
J Microsc. 2001 Sep;203(Pt 3):285-94
pubmed: 11555146
Infect Immun. 2005 Aug;73(8):4653-67
pubmed: 16040978
Infect Immun. 2010 Feb;78(2):704-15
pubmed: 19948837
PLoS One. 2012;7(3):e33320
pubmed: 22428019
Bioinformatics. 2019 Feb 1;35(3):421-432
pubmed: 30020410
Microbiology. 2010 Mar;156(Pt 3):653-64
pubmed: 19850611
J Mol Microbiol Biotechnol. 2001 Jul;3(3):355-9
pubmed: 11361065
Theory Biosci. 2012 Dec;131(4):281-5
pubmed: 22872506
PLoS Pathog. 2012;8(3):e1002574
pubmed: 22412375
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nature. 2004 Mar 18;428(6980):281-6
pubmed: 15029187
Mol Microbiol. 2004 Apr;52(1):13-24
pubmed: 15049807
Microb Drug Resist. 2012 Jun;18(3):344-58
pubmed: 22432701
Genetics. 1966 Jan;53(1):207-35
pubmed: 4379022
J Bacteriol. 2007 Nov;189(21):7856-76
pubmed: 17766420
Int J Med Microbiol. 2018 Aug;308(6):705-712
pubmed: 29398251
Genome Biol Evol. 2014 Dec 04;6(12):3281-94
pubmed: 25480686
Infect Immun. 1983 Jan;39(1):403-9
pubmed: 6822421
J Immunol. 1980 May;124(5):2502-6
pubmed: 7365262
Infect Immun. 2001 Sep;69(9):5430-9
pubmed: 11500414
J Bacteriol. 1945 Apr;49(4):401-9
pubmed: 16560933
Appl Environ Microbiol. 2001 Jan;67(1):33-41
pubmed: 11133425
Infect Immun. 2007 Jan;75(1):83-90
pubmed: 17088346
J Bacteriol. 2013 Mar;195(5):1031-41
pubmed: 23264576
J Biol Chem. 2004 May 21;279(21):22635-42
pubmed: 15016816
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
PLoS One. 2015 Mar 31;10(3):e0121042
pubmed: 25826206
PLoS Pathog. 2018 Dec 5;14(12):e1007461
pubmed: 30517198
PLoS One. 2011;6(10):e26707
pubmed: 22039538
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Mol Syst Biol. 2006;2:62
pubmed: 17102807
Bioengineered. 2012 Nov-Dec;3(6):339-42
pubmed: 22825354
Infect Immun. 2003 Jan;71(1):218-25
pubmed: 12496169
J Bacteriol. 2004 Apr;186(7):2179-94
pubmed: 15028704
Front Microbiol. 2015 Oct 07;6:1041
pubmed: 26500614
Mol Microbiol. 2007 Oct;66(1):1-13
pubmed: 17880421
Infect Immun. 2016 Oct 17;84(11):3152-3160
pubmed: 27550933
Appl Environ Microbiol. 1999 Nov;65(11):5003-8
pubmed: 10543815
PLoS One. 2013;8(3):e58492
pubmed: 23505518
BMC Bioinformatics. 2010 Mar 08;11:119
pubmed: 20211023
BMC Microbiol. 2014 Aug 28;14:210
pubmed: 25163487
PLoS Pathog. 2009 Jun;5(6):e1000476
pubmed: 19521509
FEBS Lett. 2018 Dec;592(23):3865-3897
pubmed: 29608212
J Biol Chem. 2012 Feb 3;287(6):4260-74
pubmed: 22167202
Crit Rev Microbiol. 1984;11(3):187-208
pubmed: 6391822
J Histochem Cytochem. 1986 Sep;34(9):1149-53
pubmed: 2426342

Auteurs

Lukas J Troxler (LJ)

Institute for Infectious Diseases, Faculty of Medicine, University of Bern, 3001 Bern, Switzerland.
Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.

Joel P Werren (JP)

Institute for Infectious Diseases, Faculty of Medicine, University of Bern, 3001 Bern, Switzerland.
Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.

Thierry O Schaffner (TO)

Institute for Infectious Diseases, Faculty of Medicine, University of Bern, 3001 Bern, Switzerland.

Nadezda Mostacci (N)

Institute for Infectious Diseases, Faculty of Medicine, University of Bern, 3001 Bern, Switzerland.

Peter Vermathen (P)

Department of BioMedical Research and Radiology, University of Bern and Inselspital, 3012 Bern, Switzerland.

Martina Vermathen (M)

Department of Chemistry and Biochemistry, University of Bern, 3012 Bern, Switzerland.

Daniel Wüthrich (D)

Interfaculty Bioinformatics Unit and Swiss Institute of Bioinformatics, University of Bern, 3012 Bern, Switzerland.
Applied Microbiology Research Unit, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland.
Division of Clinical Microbiology, University Hospital Basel, 4031 Basel, Switzerland.

Cedric Simillion (C)

Interfaculty Bioinformatics Unit and Swiss Institute of Bioinformatics, University of Bern, 3012 Bern, Switzerland.

Silvio D Brugger (SD)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
The Forsyth Institute (Microbiology), Cambridge, Massachusetts 02142.
Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts 02142.

Rémy Bruggmann (R)

Interfaculty Bioinformatics Unit and Swiss Institute of Bioinformatics, University of Bern, 3012 Bern, Switzerland.

Lucy J Hathaway (LJ)

Institute for Infectious Diseases, Faculty of Medicine, University of Bern, 3001 Bern, Switzerland.

Julien Furrer (J)

Department of Chemistry and Biochemistry, University of Bern, 3012 Bern, Switzerland.

Markus Hilty (M)

Institute for Infectious Diseases, Faculty of Medicine, University of Bern, 3001 Bern, Switzerland markus.hilty@ifik.unibe.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH